Healthcare >> CEO Interviews >> June 2, 2003

Bruce Given – Encysive Pharmaceuticals Inc (ency)

DR. BRUCE D. GIVEN joined Encysive Pharmaceuticals Inc. in April 2002 as President and Chief Executive Officer, and is a member of its Board of Directors. Prior to joining Encysive Pharmaceuticals, he was with Johnson & Johnson as President, International Ortho-Clinical Diagnostics, and from April 1995 to July 1998, he served as Group Vice President, Head of U.S. Marketing and Sales, Research and Development for Janssen Pharmaceutical. He has held various executive and senior management positions at Sandoz Pharma Ltd., Sandoz Research Institute and Schering-Plough Corporation. Dr. Given currently serves on the M.D. Anderson Technology Review Committee. Dr. Given obtained his MD degree with honors from the Pritzker School of Medicine, University of Chicago and completed his medical training at the University of Chicago and at Brigham and Women's Hospital in Boston, and was a Clinical Fellow at Harvard Medical School. Dr. Given is certified by the American Board of Internal Medicine and the Subspecialty Board of Endocrinology and Metabolism. Dr. Given currently serves on the M.D. Anderson Technology Review Committee. Profile
TWST: Why the name change from Texas Biotechnology to Encysive

Pharmaceuticals?

Dr. Given: We didn't think that Texas Biotechnology reflected the

company at this point. First of all, we're a